Showing results (2711-2720 of 4,619) with videos related to
Sort By:
Pageof 462
Chemmedchem|April 8, 2021
Developments in the Discovery and Design of Protein Kinase D InhibitorsPhilippe Gilles, Lauren Voets, Johan Van Lint, et al.Chemmedchem|April 13, 2021
Structure-Activity-Relationship-Aided Design and Synthesis of xCT Antiporter InhibitorsDavide Cirillo, Shahin Sarowar, Per Øyvind Enger, et al.Chemmedchem|May 23, 2012
Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide templateLigong Liu, Caiping Li, Siska Cochran, et al.Chemmedchem|May 15, 2012
The prospect of FKBP51 as a drug targetMathias V Schmidt, Marcelo Paez-Pereda, Florian Holsboer, et al.Chemmedchem|March 26, 2013
tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Maria Tardugno, et al.Chemmedchem|March 21, 2013
Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analoguesJing-Jing Shi, Fei-Hong Ji, Pei-Lan He, et al.Chemmedchem|May 3, 2012
Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffoldSanjay Samanta, Taian Cui, Yulin LamChemmedchem|April 21, 2012
Development of selective estrogen receptor modulator (SERM)-like activity through an indirect mechanism of estrogen receptor antagonism: defining the binding mode of 7-oxabicyclo[2.2.1]hept-5-ene scaffold core ligandsYangfan Zheng, Manghong Zhu, Sathish Srinivasan, et al.Chemmedchem|April 21, 2012
Docetaxel nanotechnology in anticancer therapyPengxiang Zhao, Didier AstrucChemmedchem|January 4, 2012
Selective agonists for dopamine/neurotensin receptor heterodimersSusanne Koschatzky, Peter GmeinerPageof 462